New Strong Sell Stocks for September 29th
APLD, CVCO and AMRZ have been added to the Zacks Rank #5 (Strong Sell) List on September 29, 2026.
AMRZ - Amrize AG
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$49.38
DETAILS
HIGH:
$70.00
LOW:
$32.00
MEDIAN:
$54.00
CONSENSUS:
$49.38
UPSIDE:
24.92%
Stock News
Amrize: Healthy End Markets And Margin Recovery Support The Upside
Amrize is rated Buy, driven by robust commercial and infrastructure demand, capacity expansion, and strategic M&A positioning for multi-year growth. Building Envelope margins are set to recover as recent price increases offset raw material and freight inflation, with further improvements expected in H2 2026. The ASPIRE initiative targets $250 million in savings by 2028, already delivering $29 million in Q2 2026 and supporting structural profitability.
Amrize CEO Jan Philipp Jenisch Buys 30,000 Shares for $1.3 Million. Is This a Buy Signal?
Jan Philipp Jenisch purchased 30,000 shares for a total consideration of ~$1.3 million on September 2, 2026. The transaction involved shares equal to 1% of the total equity stake held before the filing.
Do Options Traders Know Something About Amrize Stock We Don't?
Investors need to pay close attention to AMRZ stock based on the movements in the options market lately.
Amrize Appoints Mario Gross as President of Building Envelope
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Mario Gross as President, Building Envelope, effective September 11, 2026. Gross succeeds Jake Gosa, who is stepping down from the role and is committed to a smooth transition. Gross has been a member of Amrize's Executive Committee as its Chief Supply Chain Officer since the company's listing on the NYSE in June 2025. He previously served as Chief Operating Officer of the Building Envelope bus.
Here Are Wednesday’s Top Wall Street Analyst Research Calls: Ally Financial, GitLab, GLOBAL FOUNDRIES, Martin Marietta Materials, Rocket Lab USA, Strategy, Toast, Tower Semiconductor, and More
Markets took a beating Tuesday as war tensions, surging oil, and the September curse hammered stocks, bonds, and gold all at once. Find out which stocks Wall Street upgraded, downgraded, or initiated fresh coverage on as analysts scramble to reposition heading into a brutal stretch.
Amrize Ltd $AMRZ Shares Bought by Ancora Advisors LLC
Ancora Advisors LLC grew its stake in Amrize Ltd (NYSE: AMRZ) by 22.9% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 283,522 shares of the company's stock after purchasing an additional 52,759 shares during the quarter. Ancora Advisors LLC
Brokerages Set Amrize Ltd (NYSE:AMRZ) PT at $59.87
Amrize Ltd (NYSE: AMRZ - Get Free Report) has earned a consensus rating of "Moderate Buy" from the eighteen analysts that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, six have issued a hold rating, nine have given a buy rating and one has assigned a strong
Amrize Chief Strategy Officer Buys 2,510 Shares in $117,769 Transaction
The purchase involved 2,510 shares at $46.92 per share. The shares were acquired directly, with no reported indirect holdings or derivative conversions.
Amrize Appoints Sam Poletti as Chief Financial Officer
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--The Amrize (NYSE: AMRZ) Board of Directors has appointed Samuel J. Poletti as Chief Financial Officer, effective August 24. Poletti succeeds Baris Oran, who is stepping down for personal reasons. The company has also named Dillon Cumming as vice president of Investor Relations. Poletti has been a member of Amrize's Executive Committee as its Chief Strategy and M&A Officer since the company's listing on the NYSE in June 2025. Poletti led the succe.
Analyzing Amrize (NYSE:AMRZ) and Mass Megawatts Wind Power (OTCMKTS:MMMW)
Mass Megawatts Wind Power (OTCMKTS:MMMW - Get Free Report) and Amrize (NYSE: AMRZ - Get Free Report) are both materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation. Profitability This table compares Mass Megawatts Wind
Amrize Files Form 10-Q for Second Quarter 2026
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) has filed its Form 10-Q for the Second Quarter and First Half Year 2026 with the U.S. Securities and Exchange Commission. The report is also available on Amrize's website at https://investors.amrize.com/ About Amrize Amrize (NYSE: AMRZ) is building North America, as the partner of choice for professional builders with advanced branded solutions from foundation to rooftop. With over 1,000 sites and a highly efficient distribution network.
Amrize Q2 Earnings Call Highlights
Amrize NYSE: AMRZ reported second-quarter revenue growth of 8.6%, supported by demand from large commercial, infrastructure, energy and advanced-manufacturing projects, while higher freight, diesel and raw-material costs pressured profitability and led the company to update its full-year adjusted EBITDA outlook.
Amrize AG (AMRZ) Q2 2026 Earnings Call Transcript
Amrize AG (AMRZ) Q2 2026 Earnings Call Transcript
Amrize Ltd (AMRZ) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Amrize Ltd (AMRZ) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Amrize Reports Second Quarter 2026 Results
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) announced today its second quarter 2026 financial results1. Jan Jenisch, Chairman and CEO: "We delivered strong revenue growth of 8.6% in the second quarter driven by increased mega-project demand from data centers and energy to advanced manufacturing plants and infrastructure modernization. With the strength of our network and strategic footprint in the most attractive markets, we were able to achieve industry-leading organic growth of.
Amrize to Acquire Rapid Redi-Mix in Dallas-Fort Worth
CHICAGO--(BUSINESS WIRE)--Amrize (AMRZ) has entered into an agreement to acquire Rapid Redi-Mix LLC, a fast growing concrete producer in the Dallas-Fort Worth metro area. With a network of modern batch plants and mixer fleet, Rapid Redi-Mix brings significant synergies with Amrize's aggregates operations and cement network in the region.This acquisition strengthens Amrize's network in the growing Texas market adding to the recently announced production expansion of its Midlothian cement plant an.
Amrize Announces Date for Second Quarter 2026 Financial Results
CHICAGO & ZUG, Switzerland--(BUSINESS WIRE)--Amrize (AMRZ) will release its second quarter 2026 financial results after the U.S. market closes on Thursday, August 6, 2026, followed by a live webcast to discuss the company's financial results at 7:30 am Central Time on Friday, August 7, 2026. Registration for the live webcast can be completed at https://amrize-quarterly-results-q2-2026.open-exchange.net/ Amrize's financial results, presentation materials and webcast will be accessible in the eve.
Amrize: Strong Materials Momentum Can Offset Roofing Weakness
Amrize is rated a cautious Buy, supported by strong Building Materials performance and a $1B buyback program. Building Materials delivered double-digit volume growth and margin expansion, driving operating leverage and supporting 8–11% adjusted EBITDA growth guidance. Building Envelope remains a weakness due to roofing headwinds, but resolved plant disruptions and price increases could enable a second-half recovery.
Amrize to Modernize Montreal Area Cement Plant to be Most Advanced in Eastern Canada
SAINT-CONSTANT, Quebec--(BUSINESS WIRE)--Amrize (NYSE: AMRZ) today broke ground on the modernization of its cement plant outside Montreal to be the most advanced and sustainable in Eastern Canada. As the largest investment in the Canadian cement industry over the last decade, the project will introduce state-of-the-art operational efficiency and enhanced sustainability, while expanding local manufacturing and production capacity. The investment reflects Amrize's commitment to strengthen supply.
Price Targets
Amrize Ltd (AMRZ) PT Lowered to $40 at DA Davidson as FY26 Guidance 'at Risk'
$40.00
(was $36.38)
Garik Shmois
·
D.A. Davidson
Amrize price target lowered to $32 from $48 at RBC Capital
$32.00
(was $36.49)
Anthony Codling
·
RBC Capital
Amrize price target lowered to $35 from $48 at Truist
$35.00
(was $37.26)
Truist Financial
Amrize price target lowered to $40 from $44 at Wells Fargo
$40.00
(was $37.26)
Wells Fargo
Amrize initiated with an Equal Weight at Barclays
$55.00
(was $37.39)
Adam Seiden
·
Barclays
Amrize price target lowered to $56 from $64 at Deutsche Bank
$56.00
(was $38.14)
Jon Bell
·
Deutsche Bank
Amrize price target lowered to $42 from $57 at UBS
$42.00
(was $39.19)
UBS
Amrize Ltd (AMRZ) PT Lowered to $60 at Bernstein SocGen Group
$60.00
(was $37.54)
Pujarini Ghosh
·
Bernstein
Amrize price target lowered to $55 from $62 at Oppenheimer
$55.00
(was $37.44)
Oppenheimer
Amrize downgraded to Equal Weight from Overweight at Wells Fargo
$44.00
(was $41.95)
Wells Fargo
BofA Securities Downgrades Amrize Ltd (AMRZ) to Underperform
$40.00
(was $42.81)
William Blair
Amrize initiated with a Neutral at DA Davidson
$50.00
(was $45.18)
D.A. Davidson
Amrize price target lowered to $54 from $65 at Stephens
$54.00
(was $46.90)
Stephens
RBC Capital Downgrades Amrize Ltd (AMRZ) to Underperform
$48.00
(was $46.64)
Anthony Codling
·
RBC Capital
Amrize price target lowered to $58 from $65 at Wells Fargo
$58.00
(was $50.94)
Wells Fargo
Amrize downgraded to Hold from Buy at Truist
$48.00
(was $54.01)
Keith Hughes
·
Truist Financial
Amrize price target lowered to $63 from $65 at Morgan Stanley
$63.00
(was $53.42)
Morgan Stanley
Amrize price target lowered to $65 from $69 at Morgan Stanley
$65.00
(was $54.48)
Morgan Stanley
Amrize price target lowered to $68 from $70 at Oppenheimer
$68.00
(was $53.38)
Oppenheimer
Amrize upgraded to Buy from Hold at Vertical Research
$70.00
(was $53.78)
Vertical Research